chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He developed chest pain 2 days after vaccine.  No h/o dyspnea associated with the pain,  No other illnesses present to account for the pain.  When I saw him 4 days post vaccine, he was still experiencing chest pain without dyspnea or fever.  He was taking ibuprofen every 10 hours with some relief of the the pain. STAT referral placed to Cardiology on 2/21/22 at 2040.  At 2130 patient was instructed by Cardiology to present the the local hospital ER.
Admin 9-18, pt returned to rx with localized redness, pain, swelling, previous fever and chills and vomiting. Advised ibuprofen and monitoring.
2 month patient received a Flulaval dose; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2022-2023 season) (batch number pc53y, expiry date 30th June 2023) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 21st October 2022, the patient received the 1st dose of FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device. On 21st October 2022, unknown after receiving FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 31-Oct-2022 Reporter's Comment:  The nurse reported that 2 month patient received a Fulaval dose by mistake. The reporter consented to follow up.  The vaccine administration facility was the same as primary reporter. Additional Supportive Information: The 2 months patient received Flulaval dose, which led to inappropriate age at vaccine administration.
This spontaneous case initially received from other non-health care professional on 18-Oct-2018, concerning a 74-year-old, elderly, female patient. The patient had no relevant medical history. The patient's concomitant medications included Vitamins, Baby aspirin and fish oil. On 11-Oct-2018, the patient was administered with FLUAD (TIV) [dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number, expiry date: not reported). It was reported that, the patient received vaccine higher in the arm (shot in the wrong arm) and felt that it was not given correctly and was given too high (explicitly coded as incorrect route of drug administration). On 11-Oct-2018, on the same day after vaccination, the patient experienced soreness and pain in the arm. On an unspecified date in Oct-2018, the patient experienced that muscle was flapping inside the arm and tender inside the arms. The patient also felt like clicking when she moved the arm back and fourth. The patient experienced that, it was worse in the mornings when she wakes up and not as severe in the night. It was not constant, as she was aware of it in the day but not all the time. The patient did not administer any treatment measure associated with the event. At the time of this report, the patient had not recovered from the events. The reporter assessed this case as non-serious.
Patient developed itching sensation about 4 days after vaccine and it has not stopped.  She consulted her PCP who advised not to get the 2nd shot.  She is currently treating with Benadryl successfully.
Immediately following mennigococcal immunization, the client became pale diaphoretic, eyes rolled upward then he stiffened and had a blank stare for approx 15 seconds, then became alert. BP at this point 70/40, HR 48, RR 16. vital signs 2 min after episode BP 120/70 HR 60, alert and oriented.
Covid Arm - round rash area around injection site approximately 1 - 1.5 inches across.  Area is a little raised, warm to the touch, painful, and itchy.  This just started yesterday so duration and outcome is unknown.  Treatment at this time is use of Gold Bond anti-itch cream to alleviate the discomfort of the itch.
No additional adverse effects reported; one patient received one dose of improperly stored VARIVAX; This spontaneous report was received from a medical assisstant referring to a patient of unknown age and gender. The patient's pertinent medical history, historical drug, concurrent conditions and drug reactions or allergies were not reported.     On 09-MAR-2020, the patient was vaccinated with one dose of an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, subcutaneously administered (strength, dose, vaccination scheme and anatomical location were not provided), lot number S022756, which has been verified to be valid, expiration date reported and validated as 22-JUL-2021, as prophylaxis (product storage error); which was reconstituted with a properly stored sterile diluent (MERCK STERILE DILUENT).  The vaccine was exposed to a temperature of 5.7 degrees Fahrenheit (F) for a timeframe of 18 minutes. There was two previous temperature excursion, one of minus 13.3 degrees Celcius (C) and the other one of minus 13.2 degrees C, both for 18 minutes. Digital data logger was involved. No additional adverse effects were reported.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 25-APR-2013 the patient was vaccinated with a 0.65ml dose of ZOSTAVAX (lot # J000493, expired date 14-APR-2013) subcutaneously. It was reported that the patient experienced redness at injection site immediately after vaccination, on approximately 25-APR-2013. On 27-APR-2013, the patient experienced redness and bumpiness without vesicles on the arm of the injection site. The patient stated that the redness was the length of her of upper arm. It was itchy, hot and sore. The patient also stated that her lips started to swell and she had a burning sensation in her eyes. The patient also said that she had joint and muscle pain with a slightly elevated body temperature on 27-APR-2013. The patient did not seek medical attention. She took MOTRIN and BENADRYL. She stated that as of today (on 29-APR-2013) the injection site had no more bumps and the redness was going away. She did however still have stiffness in her elbows, hips and knees. Therapy with ZOSTAVAX was reported as continued. The patient status was reported as not recovered. The causality was not reported. Additional information has been requested.
TROUBLE BREATHING 5 HOURS AFTER FLU SHOT. ALSO HAD SWOLLEN EYE. PATIENT HAD ACHES AND GENERAL NOT FEELING RIGHT. HAS MANY ALLERGIES AND THIS WAS HER FIRST FLU SHOT EVER.
PATIENT HAD PAIN DURING THE INJECTION AND THEN IT WORSENED AS THE DAY (FRIDAY) WENT ON. SHE STARTED REDNESS AND SWELLING AROUND THE INJECTION SITE LATER THAT EVENING. DURING THAT EVENING THE PAIN BECAME MORE INTOLERABLE. THE NEXT MORNING (SATURDAY) SHE NOTICED THE SWELLING HAD GONE DOWN HER ARM. SHE WENT INTO URGENT CARE THAT EVENING AND THEY PRESCRIBED PREDNISONE BUT THE PHARMACY WAS CLOSED SO SHE WAS UNABLE TO FILL THE PRESCRIPTION UNTIL SUNDAY. PATIENT DID NOT TAKE ANY OVER THE COUNTER MEDICATIONS TO TRY TO HELP WITH THE PAIN. PATIENT REQUESTED BOTH VACCINATIONS BE GIVEN IN HER LEFT ARM DUE TO HAVING LYMPH NODES REMOVED IN HER RIGHT ARM.
This case was reported by a healthcare professional and described the occurrence of cellulitis leg in a 5-year-old female subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR II (non-gsk); Merck given on 26 April 2010; VARIVAX (non-gsk); Merck given on 26 April 2010. On 26 April 2010 between 15:00 and 16:00, the subject received KINRIX (.5 ml, unknown route, left thigh) as the 5th dose of the DTaP series and the 4th dose of the IPV series. The vaccine was reported as INFANRIX, but the lot number provided (AC20B139AA) corresponds to KINRIX. On 26 April 2010, less than one day after vaccination with KINRIX, the subject experienced cellulitis on left leg, injection site edema and injection site warmth. She also experienced a large leg erythema. The healthcare professional considered the events were disabling and clinically significant (or requiring intervention). The subject was treated with CEFTIN at the doctor's office, and later visited the Emergency Room. At the time of reporting the outcome of the events was unspecified.
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, lot and expiry date was unknown). The pharmacist also mentioned that at an unspecified time in the past, she had heard that a patient at their pharmacy had developed an injections site rash after receiving ZOSTAVAX, and this rash resolved on its own. This is report 2 of 2 from same reporter. Additional information has been requested.
Information has been received from a physician concerning a 75 year old male with diabetes, hypertension, gastroesophageal reflux disease and benign prostatic hyperplasia who on 14-DEC-2007 was vaccinated with 0.5 ml of Pneumovax 23 vaccine (Lot #659150/1384U) subcutaneously. Concomitant therapy included sitagliptin phosphate, tablet (MSD) (duration, dose and indication not reported). Other concomitant therapy included Metformin, rosuvastatin calcium (CRESTOR) and omeprazole (PRILOSEC). The next day,on 15-DEC-2007, the patient developed swelling and redness from the injection site down to his hand with pain in his thumb. The patient was hospitalized on 17-DEC-2007 for about 2 days and was treated with diphenhydramine hydrochloride (BENADRYL) and hydroxyzine hydrochloride (ATARAX) and was released. Laboratory diagnostics included a white blood cell count of 13,000 All symptoms were resolved in 10 days. The swelling and redness from the injection site down to his hand with pain in his thumb was considered to be an other important medical event. Additional information has been requested.
I had a bit of a reaction, swelling and rash near injection (the rash is still faint and it has been 5 days).  I had the shot Wednesday morning and Thursday night I had chills and was just overall miserable.
Arm swelled and became red and irritated. Reaction began same evening. He had done nothing to treat it. Recommended ice and ibuprofen.
12 hours after vaccine experienced flu-like symptoms with mild fever, body aches and chills and swelling and redness at injection site.   3 days later received Juvederm injected at nasolabial fold resulting in very painful swelling, redness, blisters at one of the injection sites and inside mouth. Treatment includes anti bx, antiviral and steroid. And dissolve filler.
Fever; This case was reported by a pharmacist via call center representative and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included HAB (Twinrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose and Twinrix at an unknown dose. On an unknown date, unknown after receiving Shingrix and Twinrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix and Twinrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per Shingrix vaccine indication. The patient had a fever after Twinrix or Shingrix vaccination. The reporter was not sure about which vaccine was administered by patient. The reporter did not consent to follow up. This case has been linked with US2020039898, reported by same reporter.
This spontaneous report was received from a medical assistant concerning a male patient of unknown age. On 01-AUG-2012, the patient was vaccinated with the first dose of GARDASIL (lot number, expiry date and dose unspecified), intramuscularly and would be administered with the second dose of GARDASIL vaccination series today (10-SEP-2013). No concomitant therapy was reported. No adverse effect was reported. Additional information has been requested.
pt recv vax; devel rash on face,trunk,upper thigh & back;lesions were in various stages;
Pt recvd MMR vax in 1990 & w/in 2 hrs of receiving vax pt exp dyspnea & devel hives, which were felt to be life-threatening; pt responded to tx w/Adrenalin &/or DPH; 4 addtl pts exp potenially life-threatening allergic rxns;
Received Pneumovax on 11/26/09. Chills started 11/26 pm, on 11/27, chills and temp to 102.6 F, highest reached was 103.6. Started Motrin and no fever by 11/28 pm on Motrin.
Approximately 4 hours post vax, the pt's Mom reported a fever of 101 axillary, shaking chills. The next day she reported a fever of 102.8 axillary and 2 prolonged episodes of hysterical crying lasting greater than 2 hours. All symptoms resolved by 1/19/01 at 15:00.
This was a flu shot, but I do not have the type, etc. Did not feel the actual injection and told the nurse "you're good- Thanks"  That evening, started aching in the lower bicep area and gradually got worse as the week progressed. On 10/28, arm went "flaccid" and I couldn't move it for about 10 minutes. On 10/29, pain of 10/10 with a pulsing/aching/itchy pain. The worst pain I have ever had in my life. Unable to dress, complete ADL's etc. 10/29 Saw Dr. of ortho. Unable to assess at the time due to extreme pain. He ordered oral steroids. Returned to office 11/1/18. Consulted neurology and ordered MRI. Pain went down to 3-4 after 48hrs of steroids. Since then, pain has slowly gone down to 1-2 and just very uncomfortable in the bicep area and shoulder area. It is a slow "pulsing like" feeling and is still "itchy" on the inside. Mostly bothersome at this time. Also have a sensitivity in mouth as if I burned it only since having the flu shot/oral steroids.
Extreme fatigue and then extreme vertigo. No balance at all. Also no period since injection.
Pt rec'd ROTATEQ on 10/24/11. On 10/27 developed severe vomiting, seen in ER 10/28 w. increased WBC, dehydration & U.S. questionable for intussusception. Improved w. IV hydration & diarrhea developed for 4-5 more days.
After pt received her vaccines in the morning that following evening mom noticed pt had broke out into hives. No signs of anaphylaxis. Mom called our clinic and was advised to give Benadryl. Hives mostly gone next morning.
Initial unsolicited report received from a non-healthcare professional via other company (Pfizer) on 17-AUG-2016. Manufacturer Report Number: 2016380155. This case involves a male patient (unknown age) who was vaccinated with a dose of INFLUENZA VACCINE (batch number, dose, dose in series, route and site of administration was not reported) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient developed flu. Lab data and corrective treatment were not reported. The outcome of the event was not reported. List of documents held by sender: none.
Pain, tenderness right parotid gland, right submandibular gland, right posterior pharynx. Fatigue, sleeping, general malaise. no fever or rash. feels cold.
This spontaneous report as received from an other unspecified source refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of improperly stored PNEMOVAX23 (lot # J006921, expiration date: 09-AUG-2014, dose and route not reported). This is one of several reports from the same source (linked MARRS#: 1310USA014881, 1310USA014883, 1310USA014888, 1310USA014891. 1310USA000056, 1311USA000071, 1310USA015417, 1310USA014897, 1311YSA000012, 1310USA014858, 1310USA014850, 1310USA014870, 1311USA000289, 1311USA000282, 1310USA014874, 1310USA014661, 1310USA014866, 1310USA014868, 1310USA015422, 1310USA015165, 1311USA000069, 1310USA015424, 1311USA000058, 1311USA000042, 1311USA000013, 1310USA015170, 1311USA000014, 1310USA015153, 1310USA015090, 1311USA000067, 1311USA000064. 1311USA000020, 1311USA000021, 1311USA000040, 1310USA015096, 1311USA000022, 1310USA015101, 1310USA014853, 1311USA000075, 1310USA014895, 1310USA015119, 1310USA015113, 1311USA000059, 1311USA000065, 1311USA000739. Additional information has been requested.
sore arm; massive migraine; fever of 102.5; achy body; not feeling well; room spinning; This is a spontaneous report from a contactable consumer (Patient).  A 58-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at right arm on 16Jan2021 at single dose for covid-19 immunization. The patient's medical history andconcomitant medications were not reported. The patient received the first dose of BNT162B2 (lot number: EH9199), via an unspecified route of administration at left arm on 26Dec2020 at single dose for covid-19 immunization, after the first dose she had sore arm. The patient received second dose on 16Jan2021 after getting her first one 21 days ago, she had a terrible reaction to the second one and experienced massive migraine, fever of 102.5 degrees Fahrenheit, achy body, not feeling well, sore arm, room spinning, and it has been 48 hours or if this is an adverse reaction, or what is normal. she wants to if that is side effect with the vaccine, her side effects were much stronger after the second dose. She said that she was not sure because the first time she had vaccine she had minor side effect. The patient's fever that is better today (18Jan2021), it is 100 degrees Fahrenheit. She said she still doesn't feel 100%, but her husband who was a dentist, and their friends that were dentists, no one else was having a reaction, and she was not having an allergic reaction, it was just weird. For her fever she took Tylenol. The outcome of the fever was recovering, and the outcome of the other events was unknown. Information about lot and batch number was requested.
Hives/Redness on left arm (opposite arm of injection site), buttocks, and under bra area. (Patient called and spoke with doctor already).
nausea; dizziness; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL9264), via an unspecified route of administration in the left arm on 03Feb2021 03:00 at a single dose for COVID-19 immunization. The patient has no other medical history. The patient has no known allergies. The patient has no covid prior to vaccination. The patient has not been tested for covid post vaccination. Concomitant medications included amlodipine, clopidogrel bisulfate (PLAVIX), and an unspecified statin. On 07Feb2021 at 18:00, the patient experienced nausea and dizziness when he woke up, lasted about 5 hours. No treatment was received for the reported adverse events. The outcome of the events was recovered on 07Feb2021 at 23:00.
chills; aches; exhaustion; Mostly slept; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An adult female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 ({product=COVID 19, Lot_unknown=False,, Dose_number=1}]), for COVID-19 Immunization. The following information was reported: CHILLS (non-serious), outcome "recovered", described as "chills"; PAIN (non-serious), outcome "recovered", described as "aches"; FATIGUE (non-serious), outcome "recovered", described as "exhaustion"; SOMNOLENCE (non-serious), outcome "recovered", described as "Mostly slept". It was unknown if therapeutic measures were taken as a result of chills, pain, fatigue, somnolence.  Additional Information: It was unknown if patient received any other vaccines within 4 weeks prior to the COVID vaccine, any other medications the patient received within 2 weeks of vaccination, treatment received for the adverse event, if patient diagnosed with COVID-19 prior to vaccination, if patient had been tested for COVID-19 since the vaccination, any allergies to medications, food, or other products. Hospitalization was involved for adverse event. Patient reported, 12 hrs after the shot chills, aches and exhaustion that lasted 24 hrs. Went from her bed to the couch. Mostly slept.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of SURGERY (her doctor prescribed prednisone after having a surgery) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SURGERY (her doctor prescribed prednisone after having a surgery). The patient was treated with PREDNISONE for Surgery, at an unspecified dose and frequency. At the time of the report, SURGERY (her doctor prescribed prednisone after having a surgery) had resolved. Concomitant medication of the patient was not reported. The patient reported no side effects. The patient already had two prednisone doses and read that she should not take prednisone with the vaccine.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (experienced severe reactions following vaccination and it was very unpleasant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (experienced severe reactions following vaccination and it was very unpleasant). At the time of the report, VACCINATION COMPLICATION (experienced severe reactions following vaccination and it was very unpleasant) outcome was unknown. It was reported that the patient was of a senior age group and had received two doses of the Moderna COVID-19 vaccine and then booster dose of the vaccine. No concomitant medications were reported. It was also reported by the patient that the patient did not want to report about the event as the patient already had reported it in VAERS (vaccine adverse event reporting system). No treatment information was reported.
Had adverse reaction resulting in being treated at emergency room. We administered intravenously, toradol. Before being released, also injected was Fentanyl. Was prescribed with Naproxen and take as prescribed.
I broke out in a rash/hives. I suddenly became very itchy on my face, neck, and upper torso approximately 90 minutes after 1st vaccination injection.  When I rubbed my forehead and scratched my back, the area raised into welts.  I quick took a Benadryl and did meditation, to stop me from scratching until Benadryl kicked in.  Issue disappeared by the following morning.